Back

Individualized pseudogenes networks for survival prognosis in B-cell acute lymphoblastic leukemia

Nakaramura-Garcia, A. K.; Kuijjer, M. L.; Espinal-Enriquez, J.

2025-03-18 cancer biology
10.1101/2025.03.14.643224 bioRxiv
Show abstract

Risk classification in B-cell acute lymphoblastic leukemia (B-ALL) remains challenging, even in the era of genomic precision medicine. Current molecular classifiers fail to fully explain the heterogeneity in patient outcomes, suggesting that key regulatory layers remain hidden. Here, we uncover a previously unexplored dimension of B-ALL biology by analyzing co-expression patterns between pseudogenes using single-sample co-expression networks (n = 1,416). Principal component analysis showed that these interactions explain a major component of variability among patients and contribute to patient stratification into clusters with distinct overall survival. After identifying interactions associated with these clusters, we used a LASSO-based feature selection pipeline to derive a three-interaction signature that predicted patient survival, with RPL7P10 -RPS3AP36 emerging as the most robust biomarker. Our study shows that co-expression between pseudogenes represents a previously unrecognized layer of molecular heterogeneity in B-ALL, harboring promising molecular markers for future studies.

Published in Cancer Research Communications (predicted rank #15) · training set

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.